Pemoline | |
---|---|
Molecular structure via molpic based on CDK |
Physical properties [] | |
---|---|
Molecular mass | 176.17 g/mol [1] |
Appearance | Crystals [1] |
Taste | Tasteless [1] |
Melting point | Decomp: 256-257 °C [1] |
Decomposition | When heated to decomposition it emits toxic fumes of /Nitrogen oxide/. [1] |
Solubility | Practically insol in ether, acetone, dil hydrochloric acid; sol in propylene glycol (1%) and hot alcohol [1] |
Predicted LogP | 0.9 [1] |
Structural Identifiers [] | |
---|---|
Molecular formula | C9H8N2O2 [1] |
IUPAC name | 2-amino-5-phenyl-1,3-oxazol-4-one [1] |
SMILES | C1=CC=C(C=C1)C2C(=O)N=C(O2)N [1] |
InChI | InChI=1S/C9H8N2O2/c10-9-11-8(12)7(13-9)6-4-2-1-3-5-6/h1-5,7H,(H2,10,11,12) [1] |
InChIKey | NRNCYVBFPDDJNE-UHFFFAOYSA-N [1] |
Dosing [] | |
---|---|
Elimination half-life | 7 – 12 hours |
Pemoline
Pemoline (also known as Phenoxazole, Phenylisohydantoin, Azoksodon, Fenoxazol, Azoxodon, Dantromin, Cylert, Pemolin, Tradon or Azoxodone) is a
Chemistry
Stereochemistry []
Pemoline is a racemic mixture of the optical stereoisomers
Stereoisomers |
---|
Legal status
- Australia: Pemoline is a S4 substance.
- Brazil: Pemoline is a B1 substance.[3]
- Canada: Pemoline is a Schedule IV substance.
- Germany: Pemoline is a prescription only/Anlage III substance.
- United States: Pemoline is a Schedule I under the "Controlled Substances Act (CSA)".
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 4723, Pemoline. Accessed July 13, 2025. https://pubchem.ncbi.nlm.nih.gov/compound/4723
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Pemoline. UNII: 7GAQ2332NK. Global Substance Registration System. Accessed July 13, 2025. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/7GAQ2332NK
Anvisa. RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. March 31, 2023. Accessed July 13, 2025. https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992